The biotechnology of using mesenchymal stem cells in regenerative medicine

Mesenchymal stem cells (MSCs) have garnered significant attention in regenerative medicine due to their multipotent capabilities and ability to differentiate into various cell types, including osteocytes, chondrocytes, and adipocytes. Sourced from bone marrow, adipose tissue, umbilical cord blood, and other tissues, MSCs possess immunomodulatory properties, making them ideal candidates for tissue repair and therapeutic applications. Their capacity to migrate to sites of injury and secrete bioactive molecules that promote tissue regeneration and inhibit inflammation is crucial in treating a range of conditions. Recent advancements have highlighted MSCs' role in the regeneration of bone, cartilage, cardiac tissue, and neural networks. They are also being explored in the treatment of degenerative diseases such as osteoarthritis, myocardial infarction, and neurodegenerative disorders. Despite the promising therapeutic potential, several challenges remain, such as optimizing cell delivery methods, understanding long-term effects, and addressing regulatory hurdles for clinical applications. This article aims to introduce mesenchymal stem cells and their main uses in regenerative medicine, offering a comprehensive overview of their biological properties, current clinical applications, and the potential challenges that need to be addressed for broader therapeutic use.